News Conference News AHA 2024 Nasal Bumetanide Safe, Effective in Healthy Adults Yael L. Maxwell November 18, 2024
News Conference News AHA 2024 SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity Michael O'Riordan November 16, 2024
News Conference News ESC 2024 Tri.Fr Trial Affirms Quality-of-Life Impact of Tricuspid TEER Todd Neale August 31, 2024
News Daily News Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF Michael O'Riordan July 26, 2024
News Daily News Device Correction Issued for HeartMate Monitor Due to Potential Pump Stoppage Todd Neale June 28, 2024
News Daily News The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead Michael O'Riordan June 20, 2024
News Conference News ESC Heart Failure 2024 SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM Michael O'Riordan May 13, 2024
News Daily News New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise Yael L. Maxwell May 08, 2024
News Conference News ACC 2024 Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI Shelley Wood April 06, 2024
News Conference News ACC 2024 Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF Michael O'Riordan April 06, 2024
News Daily News ACC Updates HFrEF Decision Pathway, Reinforcing the Four Pillars of Therapy Todd Neale March 11, 2024
News Conference News THT 2024 Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF Michael O'Riordan March 08, 2024
News Conference News THT 2024 Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS Michael O'Riordan March 06, 2024
Presentation THT 2024 AI Assisted Identification of Super responders for Ultrafiltration can Reduce 90-Day Readmission Rates: Evidence from AVOID-HF Trial Presenter: Deya Alkhatib March 06, 2024
News Daily News CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results Todd Neale January 23, 2024